Towards gene therapy for renal diseases

Nephrologie

Volumn 19, Issue 7, 1998, Pages 397-402

  Imai, E ^a   Akagi, Y ^a   Isaka, Y ^a  

^a OSAKA UNIVERSITY MEDICAL SCHOOL   (Japan)

Author keywords

Adenovirus; Antisense; Gene therapy; HVJ; Kidney; Liposome; Retrovirus

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; DECORIN; IMMUNOGLOBULIN G; LIPOSOME; STREPTOZOCIN; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR; VIRUS VECTOR;

ADENO ASSOCIATED VIRUS; ADENOVIRUS; ARTICLE; DIABETIC NEPHROPATHY; GENE THERAPY; GENE TRANSFER; GENETIC ENGINEERING; GLOMERULONEPHRITIS; HUMAN; KIDNEY DISEASE; KIDNEY TRANSPLANTATION; LIPID COMPOSITION; NONHUMAN; PARAINFLUENZA VIRUS 1; RETROVIRUS; URETER OBSTRUCTION;

ANIMALS; DIABETIC NEPHROPATHIES; GENE THERAPY; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; HUMANS; KIDNEY; KIDNEY DISEASES;

EID: 0031765092     PISSN: 02504960     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (40)

1. Blease R, Culver K, Miller A, Carter C, et al. T lymphocyte directed gene therapy for ADA-SCID: Initial trial results after 4 years. Science 1995; 270: 475-80.
2. Marcel T, Grausz J. The TMC worldwide gene therapy enrollment report, end 1996. Hum Gene Therapy 1997; 8: 775-800.
3. Koseki C, Herzlinger D, Al-Awqati Q. Integration of embryonic cells carrying a reporter gene into functioning nephrons. Am J Physiol 1991; 261: C550-C.
4. Bosch R, Woolf A, Fine L. Gene transfer into the mammalian kidney: Direct retrovirus transduction of regenerating tubular epithelial cells. Exp Nephrol 1993; 1: 49-54.
5. Moullier P, Friedlander G, Calise D, Ronco P, Perricaudet M, Ferry N. Adenoviral-mediated gene transfer to renal tubular cells in vivo. Kidney Int 1994; 45:1220-5.
6. Heikkila P, Parpala T, Lukkarinen O, Weber M, Tryggvason K. Adenovirus-mediated gene transfer into kidney glomeruli using an ex vivo and in vivo kidney perfusion system-first steps towards gene therapy of Alport syndrome. Gene Therapy 1996; 3: 21-7.
7. Zhu G, Nicolson A, Cowley B, Rosen S, Sukhatme V In vivo adenovirus-mediated gene transfer into normal and cystic rat kidneys. Gene Ther 1996; 3: 298-304.
8. DeMatteo R, Chu G, Ahn M, Chang E, Barker C, Markmann J. Long-lasting adenovirus transgene expression in mice through neonatal intrathymic tolerance induction without the use of immunosuppression. J Virol 1997; 71: 5330-5.
9. Leiden J. Gene therapy-promise, pitfalls, and prognosis. N Engl J Med 1995; 333: 871-3.
10. Ponnazhagan S, Erikson D, Kearns W, Zhou S, Nahreini P, Wang X, Srivastava A. Lack of site-specific integration of the recombinant adeno-asociated virus genomes in human cells. Hum Gene Ther 1997; 8: 275-84.
11. Kessler P, Podsakoff G, Chen X, McQuiston S, Cplosi P, Matelis L, Kurtzman G, Byrne B. Gene delivery to skeletal muscle results in sutained expression and systemic delivery of a therapeutic protein. Proc Natl Acad Sci USA 1996; 93: 14082-7.
12. Fisher K, Jooss K, Alston J, Yang Y, Haecker S, High K, Pathak R, Raper S, Wilson J. Recombinant adeno-associated virus for muscle directed gene therapy. Nature Med 1997; 3: 306-12.
13. Rappaport J, Hanss B, Kopp J, Copeland T, Bruggeman L, Coffman T, Klotman P. Transport of phosphorothioate oligonucleotides in kidney: Implications for molecular therapy. Kidney Int 1995; 47: 1462-9.
14. Oberbauer R, Schreiner G, Meyer T. Renal uptake of an 18-mer phosphorothioate pligonucleotide. Kidney Int 1995; 48: 1226-32.
15. Oberbauer R, Schreiner GF, Biber J, Murer H. Meyer TW. In vivo suppression of the renal Na+/Pi cotransporter by antisense oligonucleotides. Proc Natl Acad Sci USA 1996; 93: 4903-6.
16. Yanagihara I, Kaneda Y, Inui K, Okada S. Liposome-mediated gene transfer, in G. Dickson (Eds): Molecular and Cell Biology of Human Gene Therapeutics. London: Chapman & Hall, 1995.
17. Felgner P, Gadek T, Holm M, Roman R, Chan H, Wenz M, Northrop J, Ringold G, Danielsen M. Lipofectin: A highly efficient, lipidmediated DNA-transfection procedure. Proc Natl Acad Sci USA 1987; 84: 7413-7.
18. Okada Y. Sendai virus-induced cell fusion. Methods Enzymol 1993; 221: 18-41.
19. Kaneda Y, Morishita R, Tomita N. Increased expression of DNA cointroduced with nuclear protein in adult rat liver. J Mol Med 1995; 73: 289-97.
20. Akagi Y, Isaka Y, Arai M, Kaneko T, et al. Inhibition of TGF-β1 expression by antisense oligonucleotides suppressed extracellular matrix accumulation in experimental glomerulonephritis, Kidney Int 1996; 50: 148-55.
21. Imai E, Isaka Y, Akagi Y, Kaneda Y. Gene transfer into the glomerulus by the Hemagglutinating virus of Japan-liposome Method. Exp Nephrol 1997; 5: 112-7.
22. Tomita N, Higaki J, Morishita R, Kato K, Mikami H, Kaneda Y, Ogihara T. Direct in vivo gene introduction into rat kidney. Biochem Biophys Res Commun 1992; 186: 129-34.
23. Isaka Y, Fujiwara Y, Ueda N, Kaneda Y, Kamada T, Imai E. Glomerulosclerosis induced by in vivo transfection of transforming growth factor-beta or platelet-derived growth factor gene into the rat kidney. J Clin Invest 1993; 92: 2597-601.
24. Arai M, Wada A, Isaka Y, Akagi Y, et al. In vivo transfection of genes for renin and angiotensinogen into the glomerular cells induced phenotypic change of the mesangial cells and glomerular sclerosis. Biochem Biophys Res Comm 1995; 206: 525-32.
25. Kitamura M, Taylor S, Urwin R, Burton S, Shimizu F, Fine LG. Gene transfer into the rat renal glomerulus via a mesangial cell vector: Site-specific delivery, in situ amplification, and sustained expression of an exogenous gene in vivo. J Clin Invest 1994; 94: 497-505.
26. Zeigler S, Kerby J, Curiel D, Diethelm A, Thompson J. Molecular conjugate-mediated gene transfer into isolated human kidneys. Transplantaion 1996; 61: 812-7.
27. Wanger R. Gene inhibition using antisense oligodeoxynucleotides. Nature 1994; 372: 333-5.
28. Miller A Putting muscle to work for gene therapy. Nature Med 1997; 3: 278-9.
29. Tripathy S, Goldwasser E, Lu M, Barr E, Leiden J. Stable delivery of physiologic levels of recombinant erythropoietin to the systemic circulation by intramuscular injection of replication-defective adenovirus. Proc Natl Acad Sci USA 1994; 91: 11557-61.
30. Blau H, Springer M. Muscle-mediated gene thrapy. N Engl J Med 1995; 333: 1554-6.
31. Border W, Noble N, Yamamoto T, Harper J, et al. Natural Inhibitor of transforming growth factor-β protects against scarring in experimental kidney disease. Nature 1992; 360: 361-4.
32. Isaka Y, Brees DK, Ikegaya K, Kaneda Y, Imai E, Noble NA, Border WA. Gene therapy by skeletal muscle expression of decorin prevents fibrotic disease in rat kidney. Nat Med 1996; 2: 418-23.
33. Warna J, Attisano L, Wieser R, Ventura F, Massague J. Mechanism of activation of the TGF-beta receptor, nature 1994; 370: 341-7.
34. Lin H, Moustakas A, Knaus P, Wells R, Henis Y, Lodish H. The soluble exoplasmic domain of the type II transforming growth factor (TGF)-beta receptor. A heterogenous glycosylated protein with high affinity and selectivity for TGF-beta ligands. J Biol Chem 1995; 270: 2747-54.
35. Yamamoto T, Nakamura T, Noble N, Rouslahti E, Border W. Expression of transforming growth factor-b is elevated in human and experimental diabetic nephropathy. Proc Natl Acad Sci USA 1993; 90: 1814-8.
36. Wolf G, Sharma K, Ericksen M, Ziyadeh F. High glucose-induced proliferation in mesangial cells is reversed by autocrine TGF-β. Kidney Int 1992; 42: 647-56.
37. Ziyadeh F, Sharma K, Ericksen M, Wolf G, Stimulation of collagen gene expression and protein synthesis in murine mesangial cells by high glucose is mediated by autocrine activation of transforming growth factor-b. J Clin Invest 1994; 95: 536-42.
38. Sharma K, Jin Y, Guo J, Ziyadeh F. Nutralization of TGF-β by anti-TGF-β antibody attenuastes kidney hypertrophy and the enhasnced extracelluar matrix gene expression in STZ-induced diabetic mice. Diabetes 1996; 45: 522-30.
39. Klahr S. New insights into the consequences of obstructive nephropathy. Am J Kidney Dis 1991; 26: 689-99.
40. Saeki Y, Matsumoto N, Nakano Y, Mori M, Awai K, Kaneda Y. Development and characterization of cationic liposomes conjugated with HVJ (Sendai virus): Reciprocal effect of cationic lipid for in vitro and in vivo gene transfer. Human Gene Ther 1997; 8: 2133-41.